Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $35.1950 (4.22%) ($35.1950 - $35.2400) on Mon. May. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.36% (three month average) | RSI | 63 | Latest Price | $35.1950(4.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(40%) IWO(38%) IWM(37%) IWN(35%) SDY(34%) | Factors Impacting HALO price | HALO will decline at least -1.68% in a week (0% probabilities). UUP(-14%) TBT(-9%) BNDX(-9%) IGOV(-8%) VXX(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.68% (StdDev 3.36%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.82(4.07%) | 10 Day Moving Average | $33.45(5.22%) | 20 Day Moving Average | $32.71(7.6%) | To recent high | -30.1% | To recent low | 16.7% | Market Cap | $4.81b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |